East Bay aging-focused drug company lands new partner, potential half-billion-dollar payout
The Richmond company (Nasdaq: BIOA) will get a fraction of the money upfront from Novartis (NYSE: NVS) — up to $20 million, ...
Tonix Pharmaceuticals Announces FDA Acceptance of the New Drug Application (NDA) for TNX-102 SL for Fibromyalgia
FDA is expected to assign a Prescription Drug User Fee Act (PDUFA) target action date and announce whether Priority Review ...
Stockhead on MSN23h
Neurizon files key IND application with US FDA for motor neurone disease drug
Pending FDA clearance of the IND application, Neurizon said it anticipated Massachusetts General Hospital filing a protocol ...
Neurizon Files IND Application to Support HEALEY ALS Platform Trial
(ASX: NUZ & NUZOA) ("Neurizon" or "the Company"), a clinical-stage biotech company advancing treatments for neurodegenerative diseases, is pleased to announce the filing of an Investigational New Drug ...
Stocktwits on MSN13h
Tonix Pharma Stock’s Retail Chatter Explodes After FDA Nod For New Drug Application
Tonix Pharmaceuticals was the most active symbol on Stocktwits before the bell on Wednesday as shares of the clinical-stage ...
FierceBiotech2d
Where is AI winning in drug discovery? 4 use cases to know
Even though AI-designed drugs aren’t yet a household term for FDA-approved, commercially available therapies, they are a ...
Gelteq receives FDA approval of its suitability petition for new animal drug
Limited announces that the U.S. Food and Drug Administration, FDA, has approved its suitability petition for a new animal drug ...
Crinetics Announces FDA Acceptance of New Drug Application for Paltusotine for Adult Patients with Acromegaly
Paltusotine was granted Orphan Drug Designation for the treatment of acromegaly by the FDA in July 2020. This designation is provided to drugs defined as being intended for the safe and effective ...
Weight loss drugs could help end obesity - but risks remain, WHO says
LONDON - A new class of weight loss drugs developed by Novo Nordisk and Eli Lilly “opens the possibility of an end to the ...
New method of drug discovery and development offers better understanding of how drugs work
According to a new study published in Nature Communications, researchers at the Department of Laboratory Medicine, Karolinska ...
clinicaltrialsarena on MSN5d
FDA clears SpliceBio’s IND application to begin Stargardt disease therapy trial
The US FDA has granted clearance to SpliceBio’s IND application to begin the trial of SB-007, designed for Stargardt disease treatment.
Morningstar9d
Crinetics Announces FDA Acceptance of New Drug Application for Paltusotine for Adult Patients with Acromegaly
accepted its New Drug Application (NDA) for investigational candidate paltusotine for the treatment and long-term maintenance therapy of acromegaly in adults. If approved, paltusotine will be the ...